Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature

Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature

Introduction: Patients with serious comorbidities are traditionally excluded from clinical trials. Apremilast is not contraindicated in active infections, malignancy and serious hepatic or renal impairment, but real-life data is needed to support this recommendation. Objectives: The aim of this...

Full description

Bibliographic Details
Main Authors: Aikaterini Tsentemeidou, Elena Sotiriou, Nikolaos Sideris, Katerina Bakirtzi, Ilias Papadimitriou, Aimilios Lallas, Dimitrios Ioannides, Efstratios Vakirlis
Format: Article
Language:English
Published: Mattioli1885 2022-10-01
Series:Dermatology Practical & Conceptual
Subjects:
apremilast
comorbidities
medical dermatology
psoriasis
biologics
Online Access:https://www.dpcj.org/index.php/dpc/article/view/2205

Internet

https://www.dpcj.org/index.php/dpc/article/view/2205

Similar Items